Nicotine patches in Alzheimer's disease: Pilot study on learning, memory, and safety

A. Lynn Wilson; Linda K. Langley; Jan Monley; Timothy Bauer; Sue Rottunda; Edward O McFalls; Craig Kovera; J. Riley McCarten

doi:10.1016/0091-3057(95)00043-V

Nicotine patches in Alzheimer's disease: Pilot study on learning, memory, and safety

A. Lynn Wilson, Linda K. Langley, Jan Monley, Timothy Bauer, Sue Rottunda, Edward O McFalls, Craig Kovera, J. Riley McCarten

Research output: Contribution to journal › Article › peer-review

187 Scopus citations

Abstract

In view of the cholinergic deficits present in patients with Alzheimer's disease (AD), a widely investigated treatment strategy for the cognitive deficits in AD is cholinergic stimulation. Although nicotinic cholinergic receptor binding has been demonstrated to be deficient in the AD brain, the predominant theoretical and therapeutic focus to date has been on muscarinic cholinergic receptors and systems. The purpose of the present study was to evaluate the effects of sustained nicotine administration on behavior, cognition, and physiology. A double-blind placebo-controlled trial was conducted in which six patients with probable AD were exposed to 7, 8, and 7 days of placebo, nicotine, and washout, respectively. Daily sessions evaluating learning, memory, and behavior were conducted. Global cognitive functioning, rest and activity levels, cardiac activity, and blood levels were also measured. Findings included improved learning during the nicotine condition, which persisted throughout washout. Memory, behavior, and global cognition were not significantly affected. Sustained administration of nicotine appeared to be safe, although sleep showed a significant decrease.

Original language	English (US)
Pages (from-to)	509-514
Number of pages	6
Journal	Pharmacology, Biochemistry and Behavior
Volume	51
Issue number	2-3
DOIs	https://doi.org/10.1016/0091-3057(95)00043-V
State	Published - 1995
Externally published	Yes

Bibliographical note

Funding Information:
The authorsg ratefullya cknowledgeth e assistanceo f Kris Bettin and Pat Gastonguayin collectingd ata,a nd Julie Larson for building the repeateda cquisitiona pparatusT. hey also thankt he nurseso f the IntermediateC are Unit at the Departmenot f VeteransA ffairs Medical Center,M inneapolis,M innesota,w ithoutw hom this studyc ould not haveb eenc onducted,a nd James Cleary for his helpful and insightful commentsT. his researchw as supportedi n part by Lederle Laboratories, who provided the Pros@’ nicotine and placebo patchesa nd funded laboratorya ssessmenotf nicotine and cotinine levels. The work of the first author was supportebdy Grant T32 AGO0198fr om theN ationalI nstituteso f Aging.

Keywords

Actigraph
Alzheimer's disease
Behavior
Cardiac
Delayed matching to sample
Human
Learning
Memory
Nicotine
Repeated acquisition
TimeWand

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/0091-3057(95)00043-V

Cite this

Nicotine patches in Alzheimer's disease : Pilot study on learning, memory, and safety. / Wilson, A. Lynn; Langley, Linda K.; Monley, Jan; Bauer, Timothy; Rottunda, Sue; McFalls, Edward O; Kovera, Craig; McCarten, J. Riley.

In: Pharmacology, Biochemistry and Behavior, Vol. 51, No. 2-3, 1995, p. 509-514.

Research output: Contribution to journal › Article › peer-review

@article{1b9db62d12fa4a7dac062ab4521c0061,

title = "Nicotine patches in Alzheimer's disease: Pilot study on learning, memory, and safety",

abstract = "In view of the cholinergic deficits present in patients with Alzheimer's disease (AD), a widely investigated treatment strategy for the cognitive deficits in AD is cholinergic stimulation. Although nicotinic cholinergic receptor binding has been demonstrated to be deficient in the AD brain, the predominant theoretical and therapeutic focus to date has been on muscarinic cholinergic receptors and systems. The purpose of the present study was to evaluate the effects of sustained nicotine administration on behavior, cognition, and physiology. A double-blind placebo-controlled trial was conducted in which six patients with probable AD were exposed to 7, 8, and 7 days of placebo, nicotine, and washout, respectively. Daily sessions evaluating learning, memory, and behavior were conducted. Global cognitive functioning, rest and activity levels, cardiac activity, and blood levels were also measured. Findings included improved learning during the nicotine condition, which persisted throughout washout. Memory, behavior, and global cognition were not significantly affected. Sustained administration of nicotine appeared to be safe, although sleep showed a significant decrease.",

keywords = "Actigraph, Alzheimer's disease, Behavior, Cardiac, Delayed matching to sample, Human, Learning, Memory, Nicotine, Repeated acquisition, TimeWand",

author = "Wilson, {A. Lynn} and Langley, {Linda K.} and Jan Monley and Timothy Bauer and Sue Rottunda and McFalls, {Edward O} and Craig Kovera and McCarten, {J. Riley}",

note = "Funding Information: The authorsg ratefullya cknowledgeth e assistanceo f Kris Bettin and Pat Gastonguayin collectingd ata,a nd Julie Larson for building the repeateda cquisitiona pparatusT. hey also thankt he nurseso f the IntermediateC are Unit at the Departmenot f VeteransA ffairs Medical Center,M inneapolis,M innesota,w ithoutw hom this studyc ould not haveb eenc onducted,a nd James Cleary for his helpful and insightful commentsT. his researchw as supportedi n part by Lederle Laboratories, who provided the Pros@{\textquoteright} nicotine and placebo patchesa nd funded laboratorya ssessmenotf nicotine and cotinine levels. The work of the first author was supportebdy Grant T32 AGO0198fr om theN ationalI nstituteso f Aging.",

year = "1995",

doi = "10.1016/0091-3057(95)00043-V",

language = "English (US)",

volume = "51",

pages = "509--514",

journal = "Pharmacology Biochemistry and Behavior",

issn = "0091-3057",

publisher = "Elsevier Inc.",

number = "2-3",

}

TY - JOUR

T1 - Nicotine patches in Alzheimer's disease

T2 - Pilot study on learning, memory, and safety

AU - Wilson, A. Lynn

AU - Langley, Linda K.

AU - Monley, Jan

AU - Bauer, Timothy

AU - Rottunda, Sue

AU - McFalls, Edward O

AU - Kovera, Craig

AU - McCarten, J. Riley

N1 - Funding Information: The authorsg ratefullya cknowledgeth e assistanceo f Kris Bettin and Pat Gastonguayin collectingd ata,a nd Julie Larson for building the repeateda cquisitiona pparatusT. hey also thankt he nurseso f the IntermediateC are Unit at the Departmenot f VeteransA ffairs Medical Center,M inneapolis,M innesota,w ithoutw hom this studyc ould not haveb eenc onducted,a nd James Cleary for his helpful and insightful commentsT. his researchw as supportedi n part by Lederle Laboratories, who provided the Pros@’ nicotine and placebo patchesa nd funded laboratorya ssessmenotf nicotine and cotinine levels. The work of the first author was supportebdy Grant T32 AGO0198fr om theN ationalI nstituteso f Aging.

PY - 1995

Y1 - 1995

N2 - In view of the cholinergic deficits present in patients with Alzheimer's disease (AD), a widely investigated treatment strategy for the cognitive deficits in AD is cholinergic stimulation. Although nicotinic cholinergic receptor binding has been demonstrated to be deficient in the AD brain, the predominant theoretical and therapeutic focus to date has been on muscarinic cholinergic receptors and systems. The purpose of the present study was to evaluate the effects of sustained nicotine administration on behavior, cognition, and physiology. A double-blind placebo-controlled trial was conducted in which six patients with probable AD were exposed to 7, 8, and 7 days of placebo, nicotine, and washout, respectively. Daily sessions evaluating learning, memory, and behavior were conducted. Global cognitive functioning, rest and activity levels, cardiac activity, and blood levels were also measured. Findings included improved learning during the nicotine condition, which persisted throughout washout. Memory, behavior, and global cognition were not significantly affected. Sustained administration of nicotine appeared to be safe, although sleep showed a significant decrease.

AB - In view of the cholinergic deficits present in patients with Alzheimer's disease (AD), a widely investigated treatment strategy for the cognitive deficits in AD is cholinergic stimulation. Although nicotinic cholinergic receptor binding has been demonstrated to be deficient in the AD brain, the predominant theoretical and therapeutic focus to date has been on muscarinic cholinergic receptors and systems. The purpose of the present study was to evaluate the effects of sustained nicotine administration on behavior, cognition, and physiology. A double-blind placebo-controlled trial was conducted in which six patients with probable AD were exposed to 7, 8, and 7 days of placebo, nicotine, and washout, respectively. Daily sessions evaluating learning, memory, and behavior were conducted. Global cognitive functioning, rest and activity levels, cardiac activity, and blood levels were also measured. Findings included improved learning during the nicotine condition, which persisted throughout washout. Memory, behavior, and global cognition were not significantly affected. Sustained administration of nicotine appeared to be safe, although sleep showed a significant decrease.

KW - Actigraph

KW - Alzheimer's disease

KW - Behavior

KW - Cardiac

KW - Delayed matching to sample

KW - Human

KW - Learning

KW - Memory

KW - Nicotine

KW - Repeated acquisition

KW - TimeWand

UR - http://www.scopus.com/inward/record.url?scp=0029054285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029054285&partnerID=8YFLogxK

U2 - 10.1016/0091-3057(95)00043-V

DO - 10.1016/0091-3057(95)00043-V

M3 - Article

C2 - 7667377

AN - SCOPUS:0029054285

VL - 51

SP - 509

EP - 514

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 2-3

ER -

Nicotine patches in Alzheimer's disease: Pilot study on learning, memory, and safety

Abstract

Bibliographical note

Keywords

UN SDGs

Access

Other files and links

Fingerprint

Cite this